• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

促甲状腺激素(TSH)受体基因中的一种新型突变,导致TSH结合丧失,但在一个对TSH抵抗的家族中引起受体组成性激活。

A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH.

作者信息

Russo D, Betterle C, Arturi F, Chiefari E, Girelli M E, Filetti S

机构信息

Dipartimento di Scienze Farmacobiologiche, Facoltà di Farmacia, Università di Catanzaro, Italy.

出版信息

J Clin Endocrinol Metab. 2000 Nov;85(11):4238-42. doi: 10.1210/jcem.85.11.6985.

DOI:10.1210/jcem.85.11.6985
PMID:11095460
Abstract

Resistance to TSH is a syndrome due to reduced responsiveness of the thyroid gland to biologically active TSH. Inactivating mutations of the TSH receptor (TSH-R) have been detected in several cases of resistance to TSH, both partial and complete, sporadic and familial. In this study, we describe a family with the presence of resistance to TSH responsible for euthyroid hyperthyrotropinemia in two siblings from consanguineous parents. By direct sequencing of the TSH receptor gene, we identified a new mutation responsible for the substitution of an arginine with a cysteine at position 310, in the extracellular domain of the TSH-R. The mutation was homozygous in two brothers; heterozygous in both parents, an uncle, and an unaffected brother; and absent in the other unaffected brother. When stably transfected in Chinese hamster ovary cells, the Cys310 mutant TSH-R showed loss of response to TSH in terms of cAMP stimulation. However, a constitutive activity in terms of basal cAMP production was detected in the Cys310 mutant, compared with the wild-type TSH-R. Our data suggest that such a Cys310 TSH-R mutant may determine both the TSH resistance and the clinical euthyroidism detected in this family.

摘要

促甲状腺激素抵抗是一种由于甲状腺对生物活性促甲状腺激素反应性降低所致的综合征。在部分和完全性、散发性和家族性促甲状腺激素抵抗的几例病例中均检测到促甲状腺激素受体(TSH-R)的失活突变。在本研究中,我们描述了一个家族,该家族中来自近亲父母的两名同胞存在促甲状腺激素抵抗,导致甲状腺功能正常的高促甲状腺素血症。通过对促甲状腺激素受体基因进行直接测序,我们在TSH-R的细胞外结构域中鉴定出一个新的突变,该突变导致第310位的精氨酸被半胱氨酸取代。该突变在两名兄弟中为纯合子;在父母、一名叔叔和一名未受影响的兄弟中为杂合子;在另一名未受影响的兄弟中不存在。当稳定转染到中国仓鼠卵巢细胞中时,Cys310突变型TSH-R在cAMP刺激方面显示出对促甲状腺激素反应丧失。然而,与野生型TSH-R相比,在Cys310突变体中检测到基础cAMP产生方面的组成性活性。我们的数据表明,这种Cys310 TSH-R突变体可能决定了该家族中检测到的促甲状腺激素抵抗和临床甲状腺功能正常状态。

相似文献

1
A novel mutation in the thyrotropin (TSH) receptor gene causing loss of TSH binding but constitutive receptor activation in a family with resistance to TSH.促甲状腺激素(TSH)受体基因中的一种新型突变,导致TSH结合丧失,但在一个对TSH抵抗的家族中引起受体组成性激活。
J Clin Endocrinol Metab. 2000 Nov;85(11):4238-42. doi: 10.1210/jcem.85.11.6985.
2
Congenital hypothyroidism with impaired thyroid response to thyrotropin (TSH) and absent circulating thyroglobulin: evidence for a new inactivating mutation of the TSH receptor gene.伴有甲状腺对促甲状腺激素(TSH)反应受损及循环甲状腺球蛋白缺乏的先天性甲状腺功能减退症:TSH受体基因新的失活突变的证据
J Clin Endocrinol Metab. 2000 Mar;85(3):1001-8. doi: 10.1210/jcem.85.3.6460.
3
Identification of TSH receptor mutations in three families with resistance to TSH.在三个对促甲状腺激素有抵抗作用的家族中促甲状腺激素受体突变的鉴定。
Clin Endocrinol (Oxf). 2007 Nov;67(5):712-8. doi: 10.1111/j.1365-2265.2007.02950.x. Epub 2007 Aug 13.
4
Familial congenital hypothyroidism due to inactivating mutation of the thyrotropin receptor causing profound hypoplasia of the thyroid gland.由于促甲状腺激素受体失活突变导致甲状腺显著发育不全的家族性先天性甲状腺功能减退症。
J Clin Invest. 1997 Jun 15;99(12):3018-24. doi: 10.1172/JCI119497.
5
Two novel mutations in the thyrotropin (TSH) receptor gene in a child with resistance to TSH.
J Clin Endocrinol Metab. 1997 Apr;82(4):1094-100. doi: 10.1210/jcem.82.4.3863.
6
The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt/hyt mouse results in plasma membrane targeting but defective TSH binding.甲状腺功能减退的hyt/hyt小鼠中促甲状腺激素(TSH)受体跨膜结构域突变(Pro556-Leu)导致其定位于质膜,但TSH结合存在缺陷。
Endocrinology. 1995 Jul;136(7):3146-53. doi: 10.1210/endo.136.7.7789342.
7
High-affinity binding of thyrotropin to the extracellular domain of its receptor transfected in Chinese hamster ovary cells.促甲状腺激素与其在中国仓鼠卵巢细胞中表达的受体细胞外区域的高亲和力结合。
Thyroid. 1993 Summer;3(2):129-33. doi: 10.1089/thy.1993.3.129.
8
A familial thyrotropin (TSH) receptor mutation provides in vivo evidence that the inositol phosphates/Ca2+ cascade mediates TSH action on thyroid hormone synthesis.一种家族性促甲状腺激素(TSH)受体突变提供了体内证据,表明肌醇磷酸酯/Ca2+级联反应介导TSH对甲状腺激素合成的作用。
J Clin Endocrinol Metab. 2007 Jul;92(7):2816-20. doi: 10.1210/jc.2007-0366. Epub 2007 Apr 24.
9
Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.野生型促甲状腺激素受体通过与与显性促甲状腺激素抵抗相关的突变体寡聚化而被细胞内截留。
Hum Mol Genet. 2005 Oct 15;14(20):2991-3002. doi: 10.1093/hmg/ddi329. Epub 2005 Aug 31.
10
Low prevalence of thyrotropin receptor mutations in a large series of subjects with sporadic and familial nonautoimmune subclinical hypothyroidism.在一大组散发型和家族型非自身免疫性亚临床甲状腺功能减退症患者中促甲状腺激素受体突变的低发生率
J Clin Endocrinol Metab. 2004 Nov;89(11):5787-93. doi: 10.1210/jc.2004-1243.

引用本文的文献

1
Genome-wide association study of hyperthyroidism based on electronic medical record from Taiwan.基于台湾电子病历的甲状腺功能亢进症全基因组关联研究。
Front Med (Lausanne). 2022 Jul 27;9:830621. doi: 10.3389/fmed.2022.830621. eCollection 2022.
2
Genetics of primary congenital hypothyroidism-a review.原发性先天性甲状腺功能减退症的遗传学研究进展:综述
Hormones (Athens). 2021 Jun;20(2):225-236. doi: 10.1007/s42000-020-00267-x. Epub 2021 Jan 5.
3
Resistance to thyrotropin.促甲状腺素抵抗
Best Pract Res Clin Endocrinol Metab. 2017 Mar;31(2):183-194. doi: 10.1016/j.beem.2017.03.004. Epub 2017 Mar 30.
4
Identification and functional characterization of a novel thyrotropin receptor mutation (V87L) in a Chinese woman with subclinical hypothyroidism.一名中国亚临床甲状腺功能减退女性患者中新型促甲状腺激素受体突变(V87L)的鉴定与功能特征分析
Exp Ther Med. 2017 Jan;13(1):290-294. doi: 10.3892/etm.2016.3957. Epub 2016 Dec 6.
5
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cells.PDE5在人甲状腺肿瘤中的表达以及PDE5抑制剂对癌细胞生长和迁移的影响。
Endocrine. 2015 Nov;50(2):434-41. doi: 10.1007/s12020-015-0586-x. Epub 2015 Apr 3.
6
Database(d) Guidelines: A Small World.数据库(d)指南:一个小世界。
Eur Thyroid J. 2012 Oct;1(3):137-41. doi: 10.1159/000342993.
7
The molecular causes of thyroid dysgenesis: a systematic review.甲状腺发育不良的分子病因:系统评价。
J Endocrinol Invest. 2013 Sep;36(8):654-64. doi: 10.3275/8973. Epub 2013 May 22.
8
Non-autoimmune subclinical hypothyroidism due to a mutation in TSH receptor: report on two brothers.由于 TSH 受体突变引起的非自身免疫性亚临床甲状腺功能减退症:两兄弟的报告。
Ital J Pediatr. 2013 Jan 19;39:5. doi: 10.1186/1824-7288-39-5.
9
Current loss-of-function mutations in the thyrotropin receptor gene: when to investigate, clinical effects, and treatment.促甲状腺激素受体基因目前的功能丧失性突变:何时进行检测、临床影响及治疗
J Clin Res Pediatr Endocrinol. 2013;5 Suppl 1(Suppl 1):29-39. doi: 10.4274/jcrpe.864. Epub 2012 Nov 15.
10
Increased expression of pro-angiogenic factors and vascularization in thyroid hyperfunctioning adenomas with and without TSH receptor activating mutations.促血管生成因子表达增加及血管生成在甲状腺功能亢进腺瘤中的作用,有无 TSH 受体激活突变。
Endocrine. 2013 Feb;43(1):147-53. doi: 10.1007/s12020-012-9747-3. Epub 2012 Jul 20.